Intelligence
All of our intelligence products, on one page.
Four ways to work with Cannamonitor, from open reading to hands-on work, all built on the same data platform. This page is for choosing the one that matches the decision in front of you; each product page explains what is inside.
Four levels of collaborationOne platform
Decide
Decision-grade intelligence for cannabis operators and investors.
A team making decisions across markets
Platform · from €142 a seat
2Essentials
Market tracking for cannabis professionals.
One professional, one market, every month
Subscription · €14.2 a month
3Advisory
Custom, high-impact work for growth businesses.
A business that needs the work done, not just the data
Engagement · scoped
4Insights
Reports, briefs and market pages, open to all.
Anyone reading the market
Open · no login
Level 1 · Decide
Decision-grade intelligence for cannabis operators and investors.
The platform for anyone who has to act in more than one market: an operator expanding, an investor doing diligence, a business-development team building a pipeline. Everything is in one place and everything is connected.
€142 per seat per month, or €1,420 a year. Self-serve; multi-seat on request.
Level 2 · Essentials
Market tracking for cannabis professionals.
For one professional who has to stay on top of one market: the monthly brief the week it ships, a news dashboard you can filter, the analyst datapacks and the content hub behind every public article.
€14.2 a month or €142 a year, for one professional.
Compare
Which one fits the decision in front of you?
Three tiers on the same data. The difference is how many markets, how many people, and how far into the data you need to go.
Swipe the grid sideways →
Not ready to subscribe? The six pages below are open, and so is the monthly brief.
Capabilities, shown
What the platform does, shown on real markets.
Each page below is built from the same datasets the platforms run on. Each one demonstrates one thing the platform can do, on real data, and stays open for anyone to read. Each ends with a download.
A whole market, measured through its regulator.
On the page: Germany, measured.
Imports, patients, reimbursement and the operator map, each figure traced to a primary document.
Annual, final quarterly sum. 2025 was first published as 201.1 t and restated.
Measuring a market that publishes almost nothing.
On the page: Spain grows medical cannabis. It just doesn’t sell it to Spaniards.
No dispensing series exists, so the page reconciles exports from the importing regulators and publishes the conflicts it found.
Country of processing and export, not cultivation. The UK series counts flower only.
Rebuilding a market from FOI records.
On the page: The UK medical cannabis market, measured.
Item-level dispensing data recovered by freedom-of-information request, priced, and attributed along the supply chain.
Clean series. The legacy 23.9 t figure was retired and the correction published.
A regulator’s data, made comparable.
On the page: Australia, measured.
ODC and TGA releases put on one basis across time and product form, so a half-year reads against a full year.
Office of Drug Control import data, annual.
One dataset, followed across every market.
On the page: Every cannabis deal — and the companies behind them.
Parties, consideration, filings and dates for every deal, linked to the company profiles on both sides.
2026 to 11 August. Snapshot 13 August 2026.
Thirteen registries, one pipeline.
On the page: The cannabinoid pipeline, measured.
Duplicates removed across registries, phases standardised, products and sponsors resolved to company profiles.
2026 partial. Records without a start date are excluded.
Next: Canada, Pharma.
Level 3 · Advisory
Custom, high-impact work for growth businesses.
When the data is not the whole answer: project work on top of the same platform, run by the analyst who built it. Three levels; each one builds on the one before.
Level 1
Platform intelligence
A Decide subscription as the evidence base: the markets, the companies and the deals your question sits in, before anyone writes a slide.
Self-serve · from day one
Level 2
Commercial strategy engagement
A fixed-scope, six-week diagnostic: which markets to prioritise, the regulatory pathway into each, a ranked list of target accounts, the entry route, and a working session to take it into your plan.
Six weeks · fixed scope · scoped quote
Level 3
Embedded advisory
A rolling retainer: monthly working sessions, warm introductions, and ad-hoc analysis when a decision cannot wait for a report.
Monthly · rolling · scoped quote
What the work is made of
What is decided before any model runs: which sources qualify, how a market is defined, and which figure wins when two disagree. That is the work, and a person does it.
Clients and partners include
Level 4 · Insights
Read the market before you buy the data.
Reports, briefs and market pages, open to anyone. No login.
Start here
Which one is you?
I need to make operational decisions in international markets.
Decide
Day one: every market and every company in one place, cross-linked, with the deals, trials and financials behind them.
Explore Decide →I need to keep track of market trends.
Essentials
Day one: this month’s brief, the news dashboard filtered to your market, the datapack archive.
See Essentials →I need hands-on help with a market entry, a partner search or a plan.
Advisory
Day one: a thirty-minute call to scope the question, then a fixed-scope engagement or a rolling retainer.
Request a call →Why Cannamonitor specifically? The track record, the method and the people are on Connect →
Questions
The questions people ask before they buy.
Six answers, one or two sentences each. Anything else, ask.
Essentials or Decide?
Essentials if you follow one market and want the brief, the news and the datapacks behind it. Decide if you compare markets or companies, or need the deals, trials and financials cross-linked.
Can I start free?
Yes. The monthly brief is public a month after it ships, the Insights hub is open, and the six pages above are open with a download each. Essentials starts at €14.2 a month if you want the brief the week it ships.
Can’t I do this with ChatGPT and public data?
You can get a plausible answer that way; you cannot get a checked one. Every figure in Decide names its source and the person who decided it qualified. When two sources disagree we publish both and say which one we use — the Spain page shows the practice.
How fresh is it?
Around 520 classified news items are added a month. The brief ships in the first week of each month. Market datasets update when the regulator publishes, and every dataset carries its last-update date.
Multiple seats, or company-wide access?
Decide is priced per seat and multi-seat is quoted. Enterprise adds unlimited seats, API and agent access over the licensed data, and the governance a company needs around it.
Do you take on custom work?
Yes, in three levels: a Decide subscription as the evidence base, a six-week commercial strategy engagement, or a rolling advisory retainer. Ask for a call and we scope it together.
Not sure?
Not sure which one fits? Ask.
Tell us the decision you are trying to make. An analyst replies within two business days — including when the answer is that we are not the right fit.